Key facts
- Almaprism’s last known valuation is $3.6M (Apr 2025).
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Apr 2025.
- Notable investors include SBI Investment, Japan External Trade Organization, Kyoto Capital Partners (Japan), Kyoshin Social Capital, LINK-J.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Almaprism
- ·The full record, as it builds
Funding rounds
No funding rounds for Almaprism are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Almaprism
Developer of a medical video game technology designed to personalize ADHD care by analyzing behavioral patterns through interactive play. The company's technology offers a data-driven system that evaluates gameplay to guide treatment decisions and inform caregivers, enabling families, educators, and clinicians to better understand and support children with ADHD through engaging, accessible digital tools.
- Sector
- Healthcare
- HQ
- Kyoto, Japan
- Founded
- 2022
- Employees
- 3
- Website
- almaprism.com/
- Ownership
- Privately Held (backing)
Almaprism doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Almaprism shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Almaprism in its N-PORT filings yet. We sweep new filings monthly.